Figure 2.
Patients with MBDs distributed in clinical categories according to the estimated severity of bleeding by a single interviewing physician. Clinical category 1 (CC1) includes patients with more severe and CC3 those with less severe bleeding. There were a total of 280 patients, including: VWD (n = 39); PFD (n = 54); VWD + PFD (n = 9); clotting factor deficiency (CFD; n = 7); and BUC (n = 167) patients. The proportions of patients in each category of bleeding severity were not significantly different among the various disorders by χ2 test. Reproduced with permission from Quiroga et al.4